FDA Approved: GEMFIBROZIL — Supplemental Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application from Cadila Pharmaceuticals Limited for Gemfibrozil, finalizing approval of a generic version under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)